Correspondence: Christine Ecker, MSc, PhD, Department of Forensic and Neurodevelopmental Sciences, Campus PO Box 50, Institute of Psychiatry, De Crespigny Park, London SE5 8AF, England (christine.ecker@kcl.ac.uk).
Submitted for Publication: January 14, 2011; final revision received June 3, 2011; accepted July 15, 2011.
The MRC AIMS Consortium: Anthony J. Bailey, MD, PhD; Simon Baron-Cohen, PhD, FBA; Patrick Bolton; Ed T. Bullmore, MB, FRCPsych; Sarah Carrington, PhD; Bishmadev Chakrabarti, PhD; Eileen M. Daly; Sean C. Deoni, PhD; Christine Ecker, MSc, PhD; Francesca Happe, PhD; Julian Henty, PhD; Peter Jezzard, PhD; Patrick Johnston, PhD; Derek K. Jones, PhD; Meng-Chuan Lai, PhD; Michael V. Lombardo, PhD; Anya Madden; Diane Mullins, MD; Clodagh M. Murphy, MD; Declan G. M. Murphy; Greigg Pasco; Susan Sadek; Debbie Spain; Rose Steward; John Suckling, PhD; Sally Wheelwright; and Steven C. Williams, PhD.
Financial Disclosure: Dr Bullmore is employed half-time by GlaxoSmithKline and holds GlaxoSmithKline shares.
Funding/Support: This work was undertaken by the AIMS Consortium funded by the MRC UK (G0400061).
Additional Contributions: Local principal investigators included Drs Murphy, Bullmore, Baron-Cohen, and Bailey. We are grateful to the individuals who agreed to undergo MRI and who gave their time so generously to this study.